Total Payments
$4,172
2024 Payments
$1,051
Companies
25
Transactions
135
Medicare Patients
2,348
Medicare Billing
$537,332
Payment Breakdown by Category
Food & Beverage$4,103 (98.3%)
Education$69.43 (1.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,103 | 133 | 98.3% |
| Education | $69.43 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $604.17 | 14 | $0 (2024) |
| Horizon Therapeutics plc | $302.37 | 5 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $301.28 | 9 | $0 (2024) |
| Amgen Inc. | $297.86 | 14 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $274.78 | 9 | $0 (2019) |
| Alkermes, Inc. | $243.64 | 2 | $0 (2017) |
| Keryx Biopharmaceuticals, Inc. | $236.23 | 10 | $0 (2018) |
| Travere Therapeutics, Inc. | $225.95 | 7 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $222.79 | 8 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $201.77 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,051 | 46 | AstraZeneca Pharmaceuticals LP ($195.47) |
| 2023 | $853.79 | 35 | AstraZeneca Pharmaceuticals LP ($138.05) |
| 2022 | $464.01 | 11 | Horizon Therapeutics plc ($136.82) |
| 2021 | $15.83 | 1 | GlaxoSmithKline, LLC. ($15.83) |
| 2020 | $125.00 | 1 | Otsuka America Pharmaceutical, Inc. ($125.00) |
| 2019 | $624.66 | 8 | AstraZeneca Pharmaceuticals LP ($250.00) |
| 2018 | $670.62 | 23 | Mallinckrodt LLC ($240.55) |
| 2017 | $367.36 | 10 | Alkermes, Inc. ($243.64) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.93 | General |
| 10/30/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $7.97 | General |
| 10/22/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: NEPHROLOGY | ||||||
| 10/22/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: NEPHROLOGY | ||||||
| 10/15/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Immunology | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: VACCINES | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: NEPHROLOGY | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Immunology | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/06/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: NEPHROLOGY | ||||||
| 07/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/11/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: NEPHROLOGY | ||||||
| 05/22/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $13.88 | General |
| 05/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/15/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/08/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.52 | General |
| 05/07/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/02/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 565 | 1,547 | $379,213 | $116,495 |
| 2022 | 7 | 482 | 1,266 | $332,794 | $95,831 |
| 2021 | 9 | 659 | 1,957 | $531,327 | $158,636 |
| 2020 | 10 | 642 | 1,544 | $535,313 | $166,369 |
Total Patients
2,348
Total Services
6,314
Medicare Billing
$537,332
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 141 | 651 | $125,950 | $39,772 | 31.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 109 | 380 | $109,443 | $34,908 | 31.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 104 | 128 | $59,102 | $17,166 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 108 | $33,810 | $8,417 | 24.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 50 | $16,341 | $5,025 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $10,711 | $3,447 | 32.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 15 | 80 | $7,703 | $2,528 | 32.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 15 | 53 | $6,360 | $2,065 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 21 | $4,690 | $1,501 | 32.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 14 | 36 | $4,440 | $1,451 | 32.7% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 14 | 14 | $665.00 | $215.46 | 32.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 137 | 625 | $115,969 | $34,378 | 29.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 121 | 373 | $99,218 | $29,563 | 29.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 104 | 119 | $73,352 | $18,216 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 73 | $20,304 | $6,210 | 30.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 37 | 40 | $13,922 | $4,157 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $5,867 | $1,757 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 22 | $4,163 | $1,551 | 37.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 194 | 938 | $174,018 | $52,273 | 30.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 199 | 642 | $170,772 | $51,623 | 30.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 155 | 191 | $118,038 | $29,899 | 25.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 13 | 53 | $38,431 | $15,051 | 39.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 32 | 32 | $11,138 | $3,290 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 28 | $7,758 | $2,824 | 36.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 20 | $3,784 | $1,425 | 37.6% |
About Dr. Shehpar Khan, M.D
Dr. Shehpar Khan, M.D is a Internal Medicine healthcare provider based in Baytown, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2009. The National Provider Identifier (NPI) number assigned to this provider is 1356572945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shehpar Khan, M.D has received a total of $4,172 in payments from pharmaceutical and medical device companies, with $1,051 received in 2024. These payments were reported across 135 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,103).
As a Medicare-enrolled provider, Khan has provided services to 2,348 Medicare beneficiaries, totaling 6,314 services with total Medicare billing of $537,332. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Baytown, TX
- Active Since 07/31/2009
- Last Updated 05/25/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356572945
Products in Payments
- KRYSTEXXA (Biological) $389.74
- FARXIGA (Drug) $333.95
- ACTHAR (Biological) $274.78
- LOKELMA (Drug) $270.22
- Aristada 441 mg (Drug) $243.64
- Auryxia (Drug) $236.23
- LUPKYNIS (Drug) $222.79
- JYNARQUE (Drug) $211.53
- Kerendia (Drug) $201.77
- Velphoro (Drug) $192.71
- Parsabiv (Biological) $165.10
- TARPEYO (Drug) $155.45
- Renal - PD (Device) $102.53
- BENLYSTA (Biological) $101.06
- SAMSCA (Drug) $89.75
- JARDIANCE (Drug) $85.21
- RAYALDEE (Drug) $79.80
- Veltassa (Drug) $75.15
- Rayaldee (Drug) $56.76
- Fabhalta (Drug) $55.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Baytown
Dr. Dinara Rose, M.d, M.D
Internal Medicine — Payments: $7,729
Internal Medicine $7,729
Dr. Luis Gonzalez, M.d, M.D
Internal Medicine — Payments: $6,904
Internal Medicine $6,904
Atif Qureshi, M.d, M.D
Internal Medicine — Payments: $6,870
Internal Medicine $6,870
Shehzad Sami, Md, MD
Internal Medicine — Payments: $5,864
Internal Medicine $5,864
Kamran Khan, Md, MD
Internal Medicine — Payments: $4,512
Internal Medicine $4,512
Dr. Niravkumar Naik, M.d, M.D
Internal Medicine — Payments: $4,481
Internal Medicine $4,481